KALV icon

KalVista Pharmaceuticals
KALV

Overview Fund Activity

89 hedge funds and large institutions have $364M invested in KalVista Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 28 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
89
Holders Change
-8
Holders Change %
-8.25%
% of All Funds
1.41%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
11
Increased
31
Reduced
28
Closed
19
Calls
$1.66M
Puts
–
Net Calls
+$1.66M
Net Calls Change
+$1.64M

Top Buyers

1
TCM
Tang Capital Management
California
+$9.56M
2
GPP
Great Point Partners
Connecticut
+$6.81M
3
WP
Woodline Partners
California
+$5.28M
4
DTC
Deep Track Capital
Connecticut
+$3.39M
5
PM
Prosight Management
Texas
+$2.65M

Top Sellers

1
FM
Frazier Management
Washington
-$17.3M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$6.85M
3
DM
Deerfield Management
New York
-$5.08M
4
SFM
Sphera Funds Management
Israel
-$4.18M
5
EAM
Eventide Asset Management
Massachusetts
-$1.84M
Name Holding Trade Value Shares
Change 		Shares
Change %
QT
101
Quantbot Technologies
New York
– -$29K -2,200 Closed
PHK
102
Point72 Hong Kong
Hong Kong
– -$13K -1,005 Closed
FF
103
FourThought Financial
Florida
– -$9K -687 Closed
WTA
104
Washington Trust Advisors
Massachusetts
– -$1K -68 Closed
1 2 3 4
5